Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Experimental models and observational studies suggest that vitamin E supplementation may prevent cardiovascular disease and cancer. However, several trials of high-dosage vitamin E supplementation showed non-statistically significant increases in total mortality. PURPOSE: To perform a meta-analysis of the dose-response relationship between vitamin E supplementation and total mortality by using data from randomized, controlled trials. PATIENTS: 135,967 participants in 19 clinical trials. Of these trials, 9 tested vitamin E alone and 10 tested vitamin E combined with other vitamins or minerals. The dosages of vitamin E ranged from 16.5 to 2000 IU/d (median, 400 IU/d). DATA SOURCES: PubMed search from 1966 through August 2004, complemented by a search of the Cochrane Clinical Trials Database and review of citations of published reviews and meta-analyses. No language restrictions were applied. DATA EXTRACTION: 3 investigators independently abstracted study reports. The investigators of the original publications were contacted if required information was not available. DATA SYNTHESIS: 9 of 11 trials testing high-dosage vitamin E (> or =400 IU/d) showed increased risk (risk difference > 0) for all-cause mortality in comparisons of vitamin E versus control. The pooled all-cause mortality risk difference in high-dosage vitamin E trials was 39 per 10,000 persons (95% CI, 3 to 74 per 10,000 persons; P = 0.035). For low-dosage vitamin E trials, the risk difference was -16 per 10,000 persons (CI, -41 to 10 per 10,000 persons; P > 0.2). A dose-response analysis showed a statistically significant relationship between vitamin E dosage and all-cause mortality, with increased risk of dosages greater than 150 IU/d. LIMITATIONS: High-dosage (> or =400 IU/d) trials were often small and were performed in patients with chronic diseases. The generalizability of the findings to healthy adults is uncertain. Precise estimation of the threshold at which risk increases is difficult. CONCLUSION: High-dosage (> or =400 IU/d) vitamin E supplements may increase all-cause mortality and should be avoided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there have been some successes (e.g. [1633]), the results have generally been decidedly mixed, with little clinical benefit (or even actual disbenefit) following from their administration [692,1588,1634-1639]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1637]
In the citing paper
“Another meta-analysis concluded that vitamin E in high doses (400 IU) was associated with an increased risk of mortality,154 while further analyses of three large clinical trials that used a dose of about 400 IU showed no statistical differences.155”
From Age-related macular degeneration (2008) · cites this paper as [154]
In the citing paper
“Many supplements have been evaluated in observational studies and controlled trials as potential therapies to prevent CVD or other conditions (Table 4).104-110”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [106]
In the citing paper
“Evidence has accrued that most of these supplements have little CVD benefit, and that certain supplements including beta-carotene, calcium, and vitamin E may even be harmful.105-108, 111-113”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [106]
In the citing paper
“Evidence has accrued that most of these supplements have little CVD benefit, and that certain supplements including beta-carotene, calcium, and vitamin E may even be harmful.105-108, 111-113”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [106]
Citations
Cites
Hierarchical Linear Models: Applications and Data Analysis Methods.
Longford, N. T., Bryk, A. S., & Raudenbush, S. W. (1993) · Contemporary Sociology · doi:10.2307/2075823 · Cited by 18,724 · cited 2×
“In all analyses, we estimated and inferred vitamin E effects by using population-average models with robust standard errors (11, 15).”
Method(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Models for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K.-Y., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505 · cited 1×
“In all analyses, we estimated and inferred vitamin E effects by using population-average models with robust standard errors (11, 15).”
MethodA Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 1×
“ADCS, 1997 (52) United States Alzheimer disease 35 73 2000 DATATOP, 1998 (53) United States, Canada Early Parkinson disease 66 62 2000”
BackgroundStephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
(1999) · PubMed · Cited by 2,062
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Blot, W. J., Li, J.-Y., Taylor, P. R., Guo, W., Dawsey, S., Wang, G.-Q., Yang, C. S., Zheng, S.-F., Gail, M., Li, G.-Y., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1483 · Cited by 1,760 · cited 2×
“Linxian Study A, 1993 (36) China General population 45 Range, 40–69 33”
BackgroundMethodDoody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
Research works printed but not linked: 4
- Goetghebeur E, 1995, Series A, 158, 107
- McKeown-Eyssen G, 1988, Cancer Res, 48, 4701
- Richer S, 1996, J Am Optom Assoc, 67, 30
- Wluka AE, 2002, J Rheumatol, 29, 2585
Cited by
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
“One meta-analysis suggested that doses of >800 IU/day were associated with increased all-cause mortality.((186)) However, this metaanalysis has been criticized because several studies with low mortality were excluded and concomitant vitamin A and other drug administration as well as common factors, such as smoking, we…”
BackgroundFree radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Metadata
- Authors
- Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E.
- Affiliations
- Johns Hopkins University (US)
- From The Johns Hopkins School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins Medical Institutions, Baltimore, Maryland; National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; University of Edinburgh, Edinburgh, Scotland, United Kingdom; and University of Tromsø, Tromsø, Norway.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2005-01-04
- Volume
- 142
- Issue
- 1
- Pages
- 37-46
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1922087192
- Cited by
- 2,577
- References
- 73
- Citations by year
- 2026: 51 · 2025: 65 · 2024: 60 · 2023: 67 · 2022: 88 · 2021: 90 · 2020: 108 · 2019: 104 · 2018: 87 · 2017: 104 · 2016: 117 · 2015: 129 · 2014: 155 · 2013: 147 · 2012: 147
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutrition and Health Studies
- Keywords
- vitamin E supplementation, all-cause mortality, dose-response relationship, vitamin E toxicity
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Humans, Mortality, Sensitivity and Specificity, Vitamin E, Randomized Controlled Trials as Topic, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. https://app.cochat.ai/papers/10.7326/0003-4819-142-1-200501040-00110
- The paper
- Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005). Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-142-1-200501040-00110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.